Working With a World-class NanoTech Complex
This week, the company announced a partnership with the College of Nanoscale Science and Engineering (CNSE) at the University of Albany. This collaboration is particularly important for APDN as it further increases the company’s exposure to sizable defense market. APDN and the CNSE’s Albany NanoTech Complex are working together to apply a unique plant-based DNA marker to computer chips as they move through the manufacturing process. This page explains some of the world-class resources and equipment that APDN will have access to at the NanoTech Complex.
Creating anti-counterfeit solutions for computer chips in the defense industry is a $20 billion market opportunity alone, but notably, APDN is not stopping with just defense applications. Nanotechnology-driven innovations developed in partnership with the CNSE address an even larger market for nanosecurity…estimated at over $300 billion in nanoelectronics, defense, and aerospace.
APDN’s technology, which has long been successful in anti-crime applications, is branching out to prevent counterfeits in the military supply chain at just the right time. Read our post earlier this month here about the 2012 National Defense Authorization Act (NDAA), a new federal anti-counterfeiting law passed in December requiring that the Department of Defense, Department of Homeland Security, and government contractors make active efforts to detect and eliminate counterfeit parts in the military supply chain.
Continued Successes Linking Criminals to Stolen Cash in Europe
On January 13, 2012, Applied DNA revealed that its SigNature DNA® anti-crime technology was used to mark cash as part of a massive police operation to dismantle a major drug ring in the UK. Eleven drug cartel members were sentenced to a total of 31 years in prison. Greater details here.
“Our technologies are being used to obtain convictions in major crimes throughout Europe and now the US. In cases like this, where sophisticated criminals can be difficult to find and convict, our SigNature DNA makes a watertight case. It proves legally and without doubt that the criminal is linked to a specific crime.”
~ APDN’s CEO and President Dr. James Hayward on January 13, 2012
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Additional disclosure: In 2009, CRA received remuneration by Applied DNA. CRA is not presently compensated by Applied DNA, and does not hold a position in the stock. Any research issued by CRA on Applied DNA is without ratings or financial forecasts.